Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total assets, at SAR 572.5M, followed by Erasca (SAR 1.5B) and Definium Therapeutics (SAR 1.7B). Figures as of 18 Nov 2026, 16:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSAR 572.5M
- Median
- SAR 13.2B
- Combined market value
- SAR 19.07T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SAR 572.5M | SAR 19.8B | SAR 469.25 | 0.43% down | 233% up | ||
| 2 | ErascaERAS · Health Care | SAR 1.5B | SAR 17.3B | SAR 49.19 | 5.58% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | SAR 1.7B | SAR 14.7B | SAR 107.13 | 2.79% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 1.8B | SAR 30.4B | SAR 438.68 | 0.29% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | SAR 1.8B | SAR 24.5B | SAR 361.41 | 0.03% up | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | SAR 2B | SAR 18.2B | SAR 322.74 | 1.08% down | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | SAR 2.1B | SAR 16.9B | SAR 154.28 | 2.16% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | SAR 2.3B | SAR 18.1B | SAR 188.38 | 1.72% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | SAR 2.4B | SAR 27.5B | SAR 314.11 | 2.00% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | SAR 2.5B | SAR 30.7B | SAR 470.19 | 0.55% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | SAR 2.6B | SAR 26.3B | SAR 500.91 | 1.77% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | SAR 2.8B | SAR 31.8B | SAR 39.82 | 0.52% down | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 2.9B | SAR 28.3B | SAR 360.17 | 0.96% up | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | SAR 2.9B | SAR 33.9B | SAR 356.76 | 1.39% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | SAR 2.9B | SAR 24.1B | SAR 593.37 | 0.30% up | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | SAR 3.1B | SAR 27.9B | SAR 254.54 | 3.15% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | SAR 3.2B | SAR 22.4B | SAR 342.75 | 0.63% down | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | SAR 3.5B | SAR 56.7B | SAR 291.12 | 1.05% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | SAR 3.5B | SAR 18.4B | SAR 105.98 | 1.45% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | SAR 3.5B | SAR 32.1B | SAR 1,147.84 | 0.31% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | SAR 4B | SAR 36.9B | SAR 244.38 | 3.89% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 4.7B | SAR 35.4B | SAR 1,522.53 | 3.81% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 5.2B | SAR 22.8B | SAR 161.37 | 0.07% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | SAR 5.3B | SAR 26.8B | SAR 192.05 | 0.87% down | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | SAR 5.4B | SAR 66.5B | SAR 1,013.90 | 0.33% down | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | SAR 5.9B | SAR 22.5B | SAR 1,126.16 | 2.19% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | SAR 6.5B | SAR 11.8B | SAR 60.62 | 0.31% up | 42% down | ||
| 28 | InsmedINSM · Health Care | SAR 8.5B | SAR 98.7B | SAR 449.86 | 1.58% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | SAR 9.3B | SAR 29.4B | SAR 175.02 | 2.66% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SAR 10.9B | SAR 18.9B | SAR 225.89 | 0.23% down | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | SAR 13.2B | SAR 17B | SAR 102.35 | 1.21% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | SAR 13.8B | SAR 28.1B | SAR 80.68 | 1.85% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | SAR 18.6B | SAR 76.3B | SAR 569.91 | 2.92% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | SAR 21.4B | SAR 104.6B | SAR 144.36 | 0.58% down | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 23.1B | SAR 46.9B | SAR 56.21 | 1.32% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | SAR 28.5B | SAR 43.7B | SAR 225.47 | 2.73% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | SAR 29.6B | SAR 92.5B | SAR 2,172.04 | 0.86% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | SAR 30.7B | SAR 172.9B | SAR 1,513.94 | 2.34% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 43.7B | SAR 58.7B | SAR 915.08 | 1.35% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | SAR 48.3B | SAR 118.3B | SAR 191.92 | 1.53% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | SAR 50.1B | SAR 49.6B | SAR 99.14 | 2.24% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | SAR 58B | SAR 127.9B | SAR 314.69 | 0.50% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | SAR 73.6B | SAR 148.2B | SAR 257.81 | 0.07% up | 78% up | ||
| 44 | GrifolsGRFS · Health Care | SAR 82B | SAR 21.7B | SAR 31.90 | 1.45% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | SAR 96.2B | SAR 508.2B | SAR 2,004.59 | 0.04% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | SAR 139.5B | SAR 88.5B | SAR 77.23 | 0.68% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | SAR 152.1B | SAR 371.3B | SAR 3,589.07 | 0.10% down | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 152.8B | SAR 184.8B | SAR 158.35 | 0.95% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | SAR 302.2B | SAR 653.5B | SAR 148.28 | 2.87% down | 17% down | ||
| 50 | GSKGSK · Health Care | SAR 304.3B | SAR 367.1B | SAR 183.12 | 0.85% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | SAR 325.3B | SAR 679.7B | SAR 392.47 | 0.08% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | SAR 337.7B | SAR 461.4B | SAR 225.72 | 1.92% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | SAR 364.4B | SAR 256B | SAR 80.12 | 1.30% down | 54% up | ||
| 54 | NovartisNVS · Health Care | SAR 416.2B | SAR 1.1T | SAR 584.59 | 2.06% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | SAR 421.9B | SAR 4.64T | SAR 5,205.71 | 1.96% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | SAR 427.9B | SAR 1.04T | SAR 671.77 | 1.74% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | SAR 502.5B | SAR 1.92T | SAR 1,084.15 | 1.29% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | SAR 513.4B | SAR 1.29T | SAR 523.75 | 2.61% down | 51% up | ||
| 59 | SanofiSNY · Health Care | SAR 527.7B | SAR 426B | SAR 177.40 | 0.49% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | SAR 747.2B | SAR 2.49T | SAR 1,033.64 | 1.12% down | 38% up | ||
| 61 | PfizerPFE · Health Care | SAR 780.8B | SAR 601.7B | SAR 105.57 | 1.14% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals have the lowest total assets?
Veradermics (SAR 572.5M), Erasca (SAR 1.5B) and Definium Therapeutics (SAR 1.7B) have the lowest total assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:40 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of SAR 19.07T as of 18 Nov 2026, 16:40 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.